Three Japanese ministries will work jointly in the next fiscal year (from April 1) on cancer research and treatment. Cancer is the number one cause of death in Japan, responsible for approximately 360,000 deaths in 2011. The Health, Labor and Welfare Ministry; Education, Culture, Sports, Science and Technology Ministry; and the Economy, Trade and Industry […]

A survey of 38 nonprofit organizations and academic institutions conducting drug discovery research in the UK provides insight into the field and highlights its areas of need. Major challenges reported were lack of infrastructure for long-term funding and collaboration. The majority (87%) of research groups are academic, with most of their research focusing on cancer […]

While all geographic regions are primed for a strong rebound from a lackluster performance in 2013, developing markets will lead the way. Other Asia Pacific (excluding China, Japan and China), especially Taiwan, Korea and Indonesia, will perform exceptionally well. China remains the key market for most industry suppliers, while Japan offers significantly improved prospects because […]

Biotechnology R&D expenditures in Spain declined 3.3% in 2012 to €1,455 million ($1,865 million), following a 4.4% decline in 2011, to account for 11% of total Spanish R&D spending. Biotech R&D spending by government, business and higher education declined 3.7%, 2.7% 3.8% to make up 40%, 36% and 24% of total internal biotech R&D expenditures, […]

Japanese expenditures on R&D declined 0.3% in fiscal 2012 (ending March 31, 2013) to ¥17.32 trillion ($20.8 billion). This marks the first decline in two years. The ratio of R&D spending to GDP remained 3.67%. Spending by business declined 0.8% to make up 70% of all R&D expenditures. R&D spending by universities and colleges grew […]